𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of radiation therapy on quality of life of women with breast carcinoma : Results of a randomized trial

✍ Scribed by Timothy J. Whelan; Mark Levine; Jim Julian; Peter Kirkbride; Peter Skingley; Ontario Clinical Oncology Group


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
104 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

The purpose of this study was to evaluate the effect of breast irradiation on quality of life, including cosmetic outcome, for patients enrolled in a clinical trial.

METHODS.

Between 1984 and 1989, a randomized trial was conducted in Ontario, Canada, in which women with lymph node negative breast carcinoma who had undergone lumpectomy and axillary lymph node dissection were randomized to either breast irradiation or no further treatment. A modified version of the Breast Cancer Chemotherapy Questionnaire (BCQ) was administered to women at baseline, 1 month (4 weeks), and 2 months (8 weeks) after randomization. Irritation of the skin of the breast, breast pain, and appearance of the breast to the patient were also assessed every 3 months for the first 2 years of the study.

RESULTS.

Of 837 patients, 416 were randomly allocated to radiation therapy and 421 to no further treatment. The mean change in quality of life from baseline to 2 months was Οͺ0.05 for the radiation group and Ο©0.30 for the control group. The difference between groups was statistically significant (P Ο­ 0.0001). Longer term radiation therapy increased the proportion of patients who were troubled by irritation of the skin of the breast and breast pain. Radiation therapy did not increase the proportion of patients at 2 years who were troubled by the appearance of the treated breast; 4.8% in irradiated and nonirradiated patients (P Ο­ 0.62).

CONCLUSIONS.

Breast irradiation therapy had an effect on quality of life during treatment. After treatment, irradiated patients reported increased breast symptoms compared with controls. However, no difference was detected between groups at 2 years in the rates of skin irritation, breast pain, and being upset by the appearance of the breast.


πŸ“œ SIMILAR VOLUMES


A randomized controlled trial of the eff
✍ A.J. Cunningham; C.V.I. Edmonds; G.P. Jenkins; H. Pollack; G.A. Lockwood; D. War πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

In order to test the effect of a psychological intervention on survival from cancer, 66 women with metastatic breast cancer, all receiving standard medical care, were randomly assigned into two groups; one group (n = 30) attended the psychological intervention, consisting of 35 weekly, 2 h sessions

A randomized trial of tamoxifen alone or
✍ James N. Ingle; Vera J. Suman; Carl G. Kardinal; James E. Krook; James A. Mailli πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 1 views

## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act

A randomized trial comparing radiation t
✍ Carlos Manoel M. AraΓΊjo; Luis Souhami; Roberto A. Gil; Roberto Carvalho; JosΓ© A. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 388 KB

From September 1982 to December 1985, 59 previously untreated patients with Stage II squamous cell carcinoma of the thoracic esophagus were randomly assigned to receive radiation therapy (RT) alone versus the concomitant use of RT and chemotherapy (CT) with 5-fluorouracil (5-FU), mitomycin C, and bl

A randomized trial of long term adjuvant
✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w